| 1993 |
The human GNAT2 gene encodes the cone photoreceptor-specific alpha-subunit of transducin (a G-protein) and consists of 8 exons spanning ~9967 bp. The gene has multiple transcription initiation sites and its upstream region contains a TATA box, CCAAT box, and sequences distinct from rod transducin (GNAT1) and color opsin upstream regions, indicating independently regulated cone-specific expression. |
Gene characterization by sequencing, Northern blot, primer extension, S1 nuclease protection assays |
Genomics |
Medium |
8406495
|
| 1995 |
The human GNAT2 gene was mapped by fluorescence in situ hybridization (FISH) to chromosome 1p13. Screening of 66 Stargardt disease patients found no disease-causing mutations in GNAT2, indicating GNAT2 is not involved in most Stargardt disease cases (negative result). |
Fluorescence in situ hybridization (FISH) for chromosomal mapping; PCR-SSCP and direct sequencing for mutation analysis |
Genomics |
Medium |
7774932
|
| 1997 |
Expression of the GNAT2 gene is controlled by a strong silencer region between -1130 and -23, a weak cell-specific promoter between -151 and -10, and a strong downstream element between +143 and +167. DNaseI footprinting identified three major binding sites (S1, S2, S3) for putative negative trans-acting factors between -807 and -176; these factors are expressed in both retina-derived (WERI-Rb1) and non-retinal (HeLa) cell lines. |
Transfection of nested deletion CAT reporter constructs into WERI-Rb1 and HeLa cells; DNaseI footprinting; electrophoretic mobility shift assays (EMSA) with nuclear extracts |
Investigative ophthalmology & visual science |
Medium |
9008644
|
| 1998 |
A 277 bp 5'-flanking sequence from the GNAT2 gene, coupled with a 214 bp IRBP enhancer, directs cone photoreceptor-specific expression in transgenic mice, demonstrating that this upstream region is sufficient for cone-specific transcriptional activity paralleling endogenous GNAT2 expression. |
Transgenic mouse reporter assay (CAT reporter gene); immunostaining for developmental expression analysis |
Current eye research |
Medium |
9723991
|
| 2002 |
Protein-truncation mutations in GNAT2 (encoding the cone photoreceptor-specific alpha-subunit of transducin, which couples visual pigments to the phototransduction cascade) cause autosomal recessive achromatopsia, establishing GNAT2 as the third achromatopsia gene. |
Genetic linkage analysis and direct mutation sequencing in five achromatopsia families |
American journal of human genetics |
High |
12077706
|
| 2002 |
A frameshift mutation in GNAT2 exon 7 (c842_843insTCAG; M280fsX291) segregates with complete autosomal recessive achromatopsia in a large consanguineous family, mapping to chromosome 1p13, identifying GNAT2 (the gene encoding cone alpha-transducin that couples cone pigments to cGMP-phosphodiesterase) as the ACHM4 locus. |
Autozygosity mapping with microsatellite markers; direct sequence analysis of candidate gene |
Journal of medical genetics |
High |
12205108
|
| 2004 |
A leaky intronic GNAT2 mutation (c.461+24G→A) causes a splicing defect resulting in early translation termination, but small amounts of correctly spliced transcript are produced. This partial loss of function explains a milder (incomplete achromatopsia/oligocone trichromacy) phenotype compared to complete loss-of-function mutations, demonstrating a dosage-sensitive role for GNAT2 in cone phototransduction. |
Heterologous splicing experiments in COS7 cells; direct sequencing; clinical electrophysiology |
Investigative ophthalmology & visual science |
Medium |
15557429
|
| 2006 |
A missense mutation in exon 6 of Gnat2 (cpfl3 allele) in mice causes cone dysfunction with progressive loss of cone alpha-transducin immunolabeling, but cones remain structurally intact (PNA-positive outer segments) at 14 weeks, demonstrating that loss of functional GNAT2 protein leads to cone phototransduction failure without immediate cone degeneration. |
ERG, histopathology, immunocytochemistry with cone-specific markers, linkage studies, PCR sequencing |
Investigative ophthalmology & visual science |
High |
17065522
|
| 2007 |
In Gnat2(cpfl3) mutant mice lacking functional cone alpha-transducin, the secondary rod pathway (evaluated by scotopic 15-Hz flicker ERG) was completely abolished, demonstrating that GNAT2-dependent cone function is required for operation of the secondary rod signaling pathway in the retina. |
ERG recordings (scotopic flicker, intensity-response functions at multiple temporal frequencies) in Gnat2(cpfl3) mutant and C57BL/6J mice |
Experimental eye research |
Medium |
17408617
|
| 2018 |
Complete knockout of Gnat2 in mice abolishes cone phototransduction (loss of cone-driven ERG a-waves) without causing cone loss, disruption of the photoreceptor mosaic, or retinal morphological changes up to 9 months, demonstrating that GNAT2 is specifically required for cone phototransduction signal initiation but not for cone cell survival. |
Gnat2 knockout mouse generation; ERG recordings; retinal morphology and microglia/Müller glia analysis |
Experimental eye research |
High |
29518352
|
| 2022 |
In Gnat1-/-; Gnat2(cpfl3)/cpfl3 double-mutant mice (lacking both rod and cone alpha-transducin), rod and cone photoresponses are completely abolished under light-adapted conditions, yet robust visually evoked potentials persist, attributable to melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs). This establishes that GNAT2 is required for all cone-driven phototransduction input to the primary visual pathway. |
Visual evoked potential (VEP) recordings and ERG in Gnat1-/-; Gnat2(cpfl3)/cpfl3 mice |
Frontiers in cellular neuroscience |
Medium |
36605613
|
| 2023 |
GNAT2-EGFP knock-in iPSC-derived retinal organoids show that GNAT2 expression begins as early as day 34 and exclusively labels both immature and mature cone photoreceptors, enabling live tracking of individual cone morphological maturation (inner segment mitochondria accumulation, growth at 12.2 μm³/day from day 126–153), establishing GNAT2 as a reliable marker for cone identity from early differentiation. |
CRISPR/Cas9 EGFP knock-in at GNAT2 locus in human iPSCs; episodic confocal live imaging of retinal organoids |
Disease models & mechanisms |
Medium |
37902188
|
| 2025 |
In Gnat2 (cone-deficient, rod-only) mouse retinas, Sildenafil (PDE6 inhibitor) did not abolish visually evoked responses (in contrast to Gnat1 rod-deficient retinas where responses were completely removed), demonstrating that Sildenafil preferentially inhibits cone PDE6 and that GNAT2-expressing cones are the primary targets of cone phototransduction suppression by Sildenafil. |
Ex vivo multi-electrode array recordings from Gnat2 knockout and Gnat1 knockout mouse retinas with Sildenafil application |
bioRxivpreprint |
Medium |
bio_10.1101_2025.10.07.680926
|